探讨硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的临床效果

Study on Clinical Effect of Nifedipine Combined with Irbesartan in Treatment of Diabetes and Hypertension

目的研究分析糖尿病合并高血压患者接受硝苯地平联合厄贝沙坦治疗的临床效果。方法 2014年2月—2015年4月该院对60例糖尿病合并高血压患者进行了研究分析,将患者分组为对照组和观察组,对照组使用厄贝沙坦治疗,观察组使用厄贝沙坦和硝苯地平治疗,对两组的临床治疗效果进行观察分析。结果观察组患者接受治疗后的临床有效率是93.33%(28/30),患者平均舒张压是(85.37±3.43)mmHg,平均收缩压是(123.14±4.07)mmHg;对照组患者的临床治疗有效率是70.00%(21/30),平均舒张压是(93.72±4.59)mmHg,平均收缩压是(140.25±5.62)mmHg。对比分析两组结果差异有统计学意义(P<0.05),观察组较为优秀。结论糖尿病合并高血压患者接受硝苯地平联合厄贝沙坦治疗的临床效果突出,者的临床症状改善明显,血压控制稳定,临床治疗有效率比较高,患者的舒张压和收缩压显著下降,临床治疗安全性比较高,是非常优秀的药物治疗方案,在以后临床治疗中我们推介患者使用。

Objective To research and analyze the clinical effect of nifedipine combined with irbesartan in treatment of diabetes and hypertension. Methods 60 cases of patients with diabetes and hypertension treated in our hospital from February 2014 to April 2015 were selected and divided into two groups, the control group were treated with irbesartan, while the observation group were treated with nifedipine combined with irbesartan, and the clinical effect of the two groups Was observed and analyzed. Results After treatment, the differences in the clinical effective rate, average diastolic pressure and average systolic pressure between the observation group and the control group were statistically significance [93.33% （28/30）, （85.37±3.43）mmHg, （123.14±4.07）mmHg vs 70.00%（21/30）, （93.72±4.59）mmHg（ 140.25±5.62）mmHg], and these indexes in the observation group were better than those in the control group （P〈0.05）. Conclusion The clinical effect of nifedipine combined with irbesartan in treatment of diabetes and hypertension is outstanding, and the clinical symptoms are obviously improved and the blood control is steady, and the clinical treatment effective rate is higher, and the systolic pressure and diastolic pressure of patients obviously decrease and the clinical treatment safety is higher, which is a very excellent drug treatment plan, and it is worth promotion in clinical treatment.